Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Simona Carlomagno"'
Autor:
Massimiliano Gambella, Simona Carlomagno, Rosa Mangerini, Nicoletta Colombo, Alessia Parodi, Chiara Ghiggi, Livia Giannoni, Elisa Coviello, Chiara Setti, Silvia Luchetti, Alberto Serio, Antonella Laudisi, Monica Passannante, Alessandra Bo, Elisabetta Tedone, Simona Sivori, Emanuele Angelucci, Anna Maria Raiola
Publikováno v:
eJHaem, Vol 5, Iss 2, Pp 360-368 (2024)
Abstract CAR− CD4+ T cell lymphopenia is an emerging issue following CAR‐T cell therapy. We analyzed the determinants of CD4+ T cell recovery and a possible association with survival in 31 consecutive patients treated with commercial CAR‐T for
Externí odkaz:
https://doaj.org/article/bf6c9dbea539468fabc29f1c813bcaaf
Autor:
Marco Greppi, Valentina Obino, Rayan Goda, Federico Rebaudi, Simona Carlomagno, Mariella Della Chiesa, Simona Sivori, Gianluca Ubezio, Vanessa Agostini, Alessandra Bo, Silvia Pesce, Emanuela Marcenaro
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundNatural Killer cells (NKs) represent the innate counterpart of TCRαβ lymphocytes and are characterized by a high anti-tumor and an anti-viral cytotoxic activity. Recently, it has been demonstrated that NKs can express PD-1 as an additiona
Externí odkaz:
https://doaj.org/article/35381310a82a496a985bad68cfcad4ee
Autor:
Massimiliano Gambella, Simona Carlomagno, Anna Maria Raiola, Livia Giannoni, Chiara Ghiggi, Chiara Setti, Chiara Giordano, Silvia Luchetti, Alberto Serio, Alessandra Bo, Michela Falco, Mariella Della Chiesa, Emanuele Angelucci, Simona Sivori
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Surgical resection, chemotherapy and radiotherapy were, for many years, the only available cancer treatments. Recently, the use of immune checkpoint inhibitors and adoptive cell therapies has emerged as promising alternative. These cancer immunothera
Externí odkaz:
https://doaj.org/article/4ecf6947cf104064aac96ef30261cc3d
Autor:
Mariella Della Chiesa, Chiara Setti, Chiara Giordano, Valentina Obino, Marco Greppi, Silvia Pesce, Emanuela Marcenaro, Mariangela Rutigliani, Nicoletta Provinciali, Laura Paleari, Andrea DeCensi, Simona Sivori, Simona Carlomagno
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1033 (2022)
Human Natural Killer (NK) cells are all round players in immunity thanks to their powerful and immediate response against transformed cells and the ability to modulate the subsequent adaptive immune response. The potential of immunotherapies based on
Externí odkaz:
https://doaj.org/article/3b8165208dec4d8e81527873a4f75925
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
Autor:
Simona Sivori, Mariella Della Chiesa, Simona Carlomagno, Linda Quatrini, Enrico Munari, Paola Vacca, Nicola Tumino, Francesca Romana Mariotti, Maria Cristina Mingari, Daniela Pende, Lorenzo Moretta
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The highly destructive mechanisms by which the immune system faces microbial infections is under the control of a series of inhibitory receptors. While most of these receptors prevent unwanted/excessive responses of individual effector cells, others
Externí odkaz:
https://doaj.org/article/c1f40604c39a473b9c81825e3389f6ce
Autor:
Silvia Pesce, Marco Greppi, Elisa Ferretti, Valentina Obino, Simona Carlomagno, Mariangela Rutigliani, Fredrik B. Thoren, Simona Sivori, Patrizio Castagnola, Simona Candiani, Emanuela Marcenaro
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
The incidence of certain forms of tumors has increased progressively in recent years and is expected to continue growing as life expectancy continues to increase. Tumor-infiltrating NK cells may contribute to develop an anti-tumor response. Optimized
Externí odkaz:
https://doaj.org/article/c9fa013f45ce40aaadfe9aaa4b99cb2c
Autor:
Silvia Pesce, Valerio Belgrano, Marco Greppi, Simona Carlomagno, Margherita Squillario, Annalisa Barla, Mariella Della Chiesa, Stefano Di Domenico, Domenico Mavilio, Lorenzo Moretta, Simona Candiani, Simona Sivori, Franco De Cian, Emanuela Marcenaro
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Peritoneal carcinomatosis (PC) is a rare disease defined as diffused implantation of neoplastic cells in the peritoneal cavity. This clinical picture occurs during the evolution of peritoneal tumors, and it is the main cause of morbidity and mortalit
Externí odkaz:
https://doaj.org/article/bd6dd60d130d454399e70a6c39ae08c9
Autor:
Massimo Vitale, Claudia Cantoni, Mariella Della Chiesa, Guido Ferlazzo, Simona Carlomagno, Daniela Pende, Michela Falco, Annamaria Pessino, Letizia Muccio, Andrea De Maria, Emanuela Marcenaro, Lorenzo Moretta, Simona Sivori
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Natural killer (NK) cells were originally defined as effector lymphocytes of innate immunity characterized by the unique ability of killing tumor and virally infected cells without any prior priming and expansion of specific clones. The “missing-se
Externí odkaz:
https://doaj.org/article/58b598ef1cb5478599aa53987734b3bf
Autor:
Simona Carlomagno, Michela Falco, Maria Bono, Claudia Alicata, Lucia Garbarino, Michela Mazzocco, Lorenzo Moretta, Alessandro Moretta, Simona Sivori
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Several studies described an association between killer-cell immunoglobulin-like receptor (KIR)/HLA gene combinations and clinical outcomes in various diseases. In particular, an important combined role for KIR3DS1 and HLA-B Bw4-I80 in controlling vi
Externí odkaz:
https://doaj.org/article/814bdef84988457eaf91649df33e14a6
Autor:
Mariella Della Chiesa, Silvia Pesce, Letizia Muccio, Simona Carlomagno, Simona Sivori, Alessandro Moretta, Emanuela Marcenaro
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Human NK cells are distinguished into CD56brightCD16- cells and CD56dimCD16+ cells. These two subsets are conventionally associated with differential functional outcomes and are heterogeneous with respect to the expression of KIR and CD94/NKG2 hetero
Externí odkaz:
https://doaj.org/article/b6abacb5a4ef4fb3a984faa44c4611e1